Identification of cardiovascular and molecular prognostic factors for the morbidity and mortality in COVID-19-sepsis (ICROVID): Protocol for a prospective multi-centre cohort study
Open Access
- 3 June 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (6), e0269247
- https://doi.org/10.1371/journal.pone.0269247
Abstract
Severe COVID-19 constitutes a form of viral sepsis. Part of the specific pathophysiological pattern of this condition is the occurrence of cardiovascular events. These include pulmonary embolism, arrhythmias and cardiomyopathy as manifestations of extra-pulmonary organ dysfunction. Hitherto, the prognostic impact of these cardiovascular events and their predisposing risk factors remains unclear. This study aims to explore this question in two cohorts of viral sepsis–COVID-19 and influenza–in order to identify new theragnostic strategies to improve the short- and long-term outcome of these two diseases. In this prospective multi-centre cohort study, clinical assessment will take place during the acute and post-acute phase of sepsis and be complemented by molecular laboratory analyses. Specifically, echocardiography and cardiovascular risk factor documentation will be performed during the first two weeks after sepsis onset. Aside from routine haematological and biochemical laboratory tests, molecular phenotyping will comprise analyses of the metabolome, lipidome and immune status. The primary endpoint of this study is the difference in 3-month mortality of patients with and without septic cardiomyopathy in COVID-19 sepsis. Patients will be followed up until 6 months after onset of sepsis via telephone interviews and questionnaires. The results will be compared with a cohort of patients with influenza sepsis as well as previous cohorts of patients with bacterial sepsis and healthy controls. Approval was obtained from the Ethics Committee of the Friedrich Schiller University Jena (2020-2052-BO). The results will be published in peer-reviewed journals and presented at appropriate conferences. DRKS00024162.Funding Information
- Bundesministerium für Bildung und Forschung (03COV07)
This publication has 58 references indexed in Scilit:
- Clinical Spectrum, Frequency, and Significance of Myocardial Dysfunction in Severe Sepsis and Septic ShockMayo Clinic Proceedings, 2012
- The prognostic value of left ventricular systolic function measured by tissue Doppler imaging in septic shockCritical Care, 2012
- Diastolic dysfunction and mortality in severe sepsis and septic shockEuropean Heart Journal, 2011
- Outcomes in severe sepsis and patients with septic shock: Pathogen species and infection sites are not associated with mortality*Critical Care Medicine, 2011
- Septic cardiomyopathyAnnals of Intensive Care, 2011
- Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock*Critical Care Medicine, 2007
- N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shockCritical Care, 2007
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- APACHE IICritical Care Medicine, 1985
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969